DR. PHILLIPS IS LEADING TWO NEWÂ
RHEUMATIC DISEASE STUDIES!
​
STUDY #1 M20-466 for individuals with Rheumatoid Arthritis
​
Rheumatoid arthritis (RA) is a chronic autoimmune disease that mainly causes symptoms such as painful, swollen joints, stiffness, and fatigue. A substantial proportion of patients with RA don’t respond well to currently available RA therapies. Therefore, there is still a medical need for more effective RA treatments that work in different ways.
Dr. Phillips is conducting a clinical study that needs volunteers to help find out whether an investigational medication works and how safe it is for people who have RA.
Interested in participating in this study? Text (270) 994-9926 or call (270) 477-1600 to schedule a confidential informational visit with the study coordinator at our office.
​
NOTE: During the informational visit, the coordinator will review your reported medical history, review the study consent form in detail and do a basic review of preliminary eligibility criteria. At the conclusion of the informational visit, the patient will be given the opportunity to screen for the study, if appropriate.
​
If you are interested in learning more, please visit www.contrastraprogram.com.
​
STUDY #2 M20-370 for individuals with
Polymyalgia Rheumatica
​
Polymyalgia Rheumatic is an inflammatory disorder that causes muscle pain and stiffness, especially in the shoulders and hips. A substantial proportion of patients with Polymyalgia Rheumatica don’t respond well to currently available therapies. Therefore, there is still a medical need for more effective Polymyalgia Rheumatica treatments that work in different ways.
Dr. Phillips is conducting a clinical study that needs volunteers to help find out whether an investigational medication works and how safe it is for people who have Polymyalgia Rheumatica.
Interested in participating in this study? Text (270) 994-9926 or call (270) 477-1600 to schedule a confidential informational visit with the study coordinator at our office.
​
NOTE: During the informational visit, the coordinator will review your reported medical history, review the study consent form in detail and do a basic review of preliminary eligibility criteria. At the conclusion of the informational visit, the patient will be given the opportunity to screen for the study, if appropriate.
​
If you are interested in learning more, please visit www.contrastraprogram.com.
​
​